Related Experiment Video
Updated: Jun 25, 2026

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Cardiovascular Outcomes in Fontan Patients With Right vs Left Univentricular Morphology: A Multicenter Study
Nabil Dib1, Marie-A Chaix1, Michelle Samuel1
1Montreal Heart Institute, Université de Montréal, Quebec, Canada.
Insights
Patients with a univentricular right (uRV) ventricle after Fontan palliation face higher risks of adverse cardiovascular events, including arrhythmias and death, compared to those with a univentricular left (uLV) ventricle.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Congenital Heart Disease
Background:
- Limited data exists on long-term outcomes for Fontan palliation patients based on dominant ventricle morphology.
- Distinguishing outcomes between univentricular right (uRV) and univentricular left (uLV) ventricle morphology is crucial.
Purpose of the Study:
- To compare the incidence of atrial arrhythmias, thromboembolic events, cardiac transplantation, and death in patients with uRV versus uLV morphology post-Fontan palliation.
- To identify differential risks associated with dominant ventricle type following Fontan surgery.
Main Methods:
- A multicenter retrospective cohort study involving 384 patients with total cavopulmonary connection Fontan palliation.
- Blinded adjudication of composite outcomes (atrial arrhythmias, thromboembolic events, transplantation, death) and time-to-event analyses accounting for competing risks.
Main Results:
- The composite outcome occurred more frequently in uRV patients (3.7 per 100 person-years) compared to uLV patients (1.7 per 100 person-years).
- uRV morphology conferred a >2-fold higher risk of the composite outcome (HR: 2.17).
- uRV was significantly associated with increased risk of cardiac transplantation or death (HR: 9.09) and atrial arrhythmias (HR: 2.17).
Conclusions:
- Fontan patients with uRV morphology exhibit a higher incidence of adverse cardiovascular events compared to those with uLV morphology.
- These events include atrial arrhythmias, cardiac transplantation, and all-cause mortality, highlighting the prognostic significance of dominant ventricle type.
Background:
There is a paucity of data on long-term outcomes after Fontan palliation in patients with a dominant morphological univentricular right (uRV) vs left (uLV) ventricle.
Objectives:
The purpose of this study was to compare the incidence of atrial arrhythmias, thromboembolic events, cardiac transplantation, and death following Fontan palliation in patients with uRV vs uLV.
Methods:
The Alliance for Adult Research in Congenital Cardiology conducted a multicenter retrospective cohort study on patients with total cavopulmonary connection Fontan palliation across 12 centers in North America. All components of the composite outcome, that is, atrial arrhythmias, thromboembolic events, cardiac transplantation, and death, were reviewed and classified by a blinded adjudicating committee. Time-to-event analyses were performed that accounted for competing risks.
Results:
A total of 384 patients were followed for 10.5 ± 5.9 years. The composite outcome occurred in 3.7 vs 1.7 cases per 100 person-years for uRV (N = 171) vs uLV (N = 213), respectively (P < 0.001). In multivariable analyses, uRV conferred a >2-fold higher risk of the composite outcome (HR: 2.17, 95% CI: 1.45-3.45, P < 0.001). In secondary analyses of components of the primary outcome, uRV was significantly associated with a greater risk of cardiac transplantation or death (HR: 9.09, 95% CI: 2.17-38.46, P < 0.001) and atrial arrhythmias (HR: 2.17, 95% CI: 1.20-4.00, P = 0.010) but not thromboembolic events (HR: 1.64, 95% CI: 0.86-3.16, P = 0.131).
Conclusions:
Fontan patients with uRV vs uLV morphology have a higher incidence of adverse cardiovascular events, including atrial arrhythmia, cardiac transplantation, and all-cause mortality.
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Mitral Stenosis I: Introduction

